Abstract: Sterilization packaging systems with features for sealing a volume against an ingress of contaminants are provided. Such features include a sealing assembly including a gasket and a sheet of filter material. The sealing assembly seals a lid to a seal rim of a base. The gasket has an upper surface, outer edge, and inner edge. The upper surface of the gasket comprises a first row of alternating protrusions and indentations and a second row of alternating protrusions and indentations that define a channel therebetween. The sheet of filter material extends from an inner edge of the gasket. The gasket completely surrounds the sheet of filter material, wherein the indentations and channel facilitate delivery of a sterilization agent through the filter material. A sterilization assembly including a lid having a plurality of protrusions in its upper surface in conjunction with a gasket having a smooth upper surface is also provided.

Abstract: The present disclosure provides sterilization containers with features for sealing a volume against an ingress of contaminants. The present disclosure also provides a sterility breach detection system for detecting whether the sterilization container seal has been breached, which potentially could compromise the sterility of any contents of the container. Further, the present disclosure provides a controller system for detecting, tracking, and alerting a user to the state of a sterilization container, such as whether the container seal has been breached. The sterility breach detection system and/or the controller system may utilize a smart gasket to detect breaches in a seal of a sterilization container, and a controller in operative communication with the smart gasket may activate an indicator to alert a user to a detected breach in the seal.

Abstract: Indicators for indicating the integrity of a seal of a sterilization container are provided. For example, a seal indicator may indicate whether the container is sufficiently sealed to prevent an ingress of contaminants into the container. If the container is sufficiently sealed, the seal indicator is in one state and displays a first indicium, and if the sterilization container is not sufficiently sealed, the seal indicator is in another state and displays a second indicium. Thus, the seal indicator undergoes a visible change in state when the sterilization container transitions from unsealed to sealed, such that the user may be assured that the container is properly sealed to maintain sterility of the articles post-sterilization. Further, the seal indicator undergoes a visible change in state if the seal is subsequently broken, to signal to the user that the seal and the sterility of the container interior has been compromised.

Abstract: A head cover that can be worn by health care professionals is provided. The head cover includes a surgical cap portion and a bouffant cap portion. The surgical cap portion includes a top surface and a side panel secured to the top surface via a seam. Further, the bouffant cap portion is secured to a rear portion of the side panel, where the bouffant cap portion is maintained against the rear portion of the side panel in an undeployed state and is deployable from the rear portion of the side panel to contain a wearer's hair. As such, the head cover enables a wearer to secure his or her hair inside the bouffant cap as needed, yet bouffant cap portion does not cover the wearer's entire head, which minimizes the amount of heat that is trapped within the head cover and increases the level of comfort for the wearer.

Abstract: The present invention provides a pharmaceutical composition comprising mesenchymal stem cells, a hyaluronan and a pharmaceutically acceptable carrier. The pharmaceutical composition is used for the treatment of the joint disease. The mesenchymal stem cells in the composition are at least one selected from the group consisting of infra-patellar fat pad stromal cells, bone marrow stem cells, Wharton's jelly stem cells and adipose derived stem cells. The concentration of the hyaluronan is in a range from 25% (v/v) to 75% (v/v). The present invention further provides a method for treating a joint disease, comprising a step of administrating a composition containing mesenchymal stem cells, a hyaluronan and a pharmaceutically acceptable carrier to an injured joint tissue of a subject.

Abstract: A wristwatch that includes a concave lens and concave dial contained within a bezel and housing. The concave shape of the lens causes the upper most surface of the wristwatch to be the bezel, so the upper surface of the lens cannot be scratch if the user places the watch face down on a surface. The concave shape of the dial causes an increase in surface area for time marking indicia on the dial face. This effect combines with the concave angle of the lens to increase the appearance of the indicia and reduce glare.

Abstract: A case for receiving and dispensing pills, having an optional top cover having a forward edge and a rearward edge, an optional bottom cover having a forward edge and a rearward edge, a spine extending between the top cover and the bottom cover, to which the top cover and the bottom cover are affixed at the rearward edges thereof, and at least one sleeve containing a plurality of pills secured within the sleeve and adapted to be dispensed therefrom, the sleeve having a forward edge and a rearward edge and being attached to the spine at the rearward edge thereof between the top cover and the bottom cover.

Abstract: A wristwatch that includes a concave lens and concave dial contained within a bezel and housing. The concave shape of the lens causes the upper most surface of the wristwatch to be the bezel, so the upper surface of the lens cannot be scratch if the user places the watch face down on a surface. The concave shape of the dial causes an increase in surface area for time marking indicia on the dial face. This effect combines with the concave angle of the lens to increase the appearance of the indicia and reduce glare.

Abstract: A child-resistant pill bottle combines the child resistance of a “push and turn” pill bottle and the compliance feature of a pill tray. The pill bottle includes a container for holding medication, a pill tray formed to fit either within the container or integrated into the container, and a lid, which traps the pill tray within the container.